Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 13/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | FAP | Q12884 | 5/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5775989 | 0.89 | DPP4 (0.46) | DPP4L3MBTL1ALDH1A1FAPDPP9 | |
| Trifluoroacetic Acid SCHEMBL5718943 | 0.85 | DPP4 (0.54) | DPP4L3MBTL1ALDH1A1FAPNUDT5 | |
| Trifluoroacetic Acid SCHEMBL6384005 | 0.84 | DPP4 (0.47) | DPP4L3MBTL1ALDH1A1FAPNUDT5 | |
| Trifluoroacetic Acid SCHEMBL5719312 | 0.83 | DPP4 (0.50) | DPP4L3MBTL1ALDH1A1FAPDPP9 | |
| SCHEMBL5719316 | 0.83 | DPP4 (0.44) | DPP4L3MBTL1ALDH1A1FAPDPP9 | |
| Trifluoroacetic Acid SCHEMBL5719425 | 0.83 | DPP4 (0.51) | DPP4L3MBTL1ALDH1A1FAPDPP9 | |
| Trifluoroacetic Acid SCHEMBL5719389 | 0.83 | ALDH1A1 (0.50) | DPP4L3MBTL1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL6692692 | 0.82 | LMNA (0.49) | DPP4L3MBTL1ALDH1A1FAPHTT | |
| Trifluoroacetic Acid SCHEMBL5719494 | 0.81 | DPP4 (0.58) | DPP4L3MBTL1ALDH1A1GAAHTT | |
| Trifluoroacetic Acid SCHEMBL5718920 | 0.81 | DPP4 (0.51) | DPP4L3MBTL1ALDH1A1NUDT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060094722-A1 | Combination drug | EISAI CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094722-A1 | Combination drug | DPP4, GLP1R, DPP7 | DPP4 1/4885L3MBTL1 4196/4885ALDH1A1 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.